Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway. [electronic resource] by
- Shen, Y
- Park, C S
- Suppipat, K
- Mistretta, T-A
- Puppi, M
- Horton, T M
- Rabin, K
- Gray, N S
- Meijerink, J P P
- Lacorazza, H D
Producer: 20171017
In:
Leukemia vol. 31
Availability: No items available.
|
|
11.
|
Endogenous knockdown of survivin improves chemotherapeutic response in ALL models. [electronic resource] by
- Morrison, D J
- Hogan, L E
- Condos, G
- Bhatla, T
- Germino, N
- Moskowitz, N P
- Lee, L
- Bhojwani, D
- Horton, T M
- Belitskaya-Levy, I
- Greenberger, L M
- Horak, I D
- Grupp, S A
- Teachey, D T
- Raetz, E A
- Carroll, W L
Producer: 20120330
In:
Leukemia vol. 26
Availability: No items available.
|
|
12.
|
JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias. [electronic resource] by
- Delgado-Martin, C
- Meyer, L K
- Huang, B J
- Shimano, K A
- Zinter, M S
- Nguyen, J V
- Smith, G A
- Taunton, J
- Winter, S S
- Roderick, J R
- Kelliher, M A
- Horton, T M
- Wood, B L
- Teachey, D T
- Hermiston, M L
Producer: 20171215
In:
Leukemia vol. 31
Availability: No items available.
|